1. Home
  2. MRUS vs KFY Comparison

MRUS vs KFY Comparison

Compare MRUS & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • KFY
  • Stock Information
  • Founded
  • MRUS 2003
  • KFY 1969
  • Country
  • MRUS Netherlands
  • KFY United States
  • Employees
  • MRUS N/A
  • KFY N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • KFY Diversified Commercial Services
  • Sector
  • MRUS Health Care
  • KFY Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • KFY Nasdaq
  • Market Cap
  • MRUS 4.1B
  • KFY 3.9B
  • IPO Year
  • MRUS 2016
  • KFY 1999
  • Fundamental
  • Price
  • MRUS $66.82
  • KFY $73.72
  • Analyst Decision
  • MRUS Strong Buy
  • KFY Buy
  • Analyst Count
  • MRUS 13
  • KFY 2
  • Target Price
  • MRUS $88.54
  • KFY $80.00
  • AVG Volume (30 Days)
  • MRUS 645.9K
  • KFY 511.8K
  • Earning Date
  • MRUS 08-04-2025
  • KFY 09-04-2025
  • Dividend Yield
  • MRUS N/A
  • KFY 2.61%
  • EPS Growth
  • MRUS N/A
  • KFY 42.44
  • EPS
  • MRUS N/A
  • KFY 4.60
  • Revenue
  • MRUS $54,732,000.00
  • KFY $2,730,088,000.00
  • Revenue This Year
  • MRUS $68.08
  • KFY $3.15
  • Revenue Next Year
  • MRUS $0.09
  • KFY $4.79
  • P/E Ratio
  • MRUS N/A
  • KFY $16.02
  • Revenue Growth
  • MRUS 42.77
  • KFY N/A
  • 52 Week Low
  • MRUS $33.19
  • KFY $59.23
  • 52 Week High
  • MRUS $67.07
  • KFY $80.64
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 77.27
  • KFY 54.58
  • Support Level
  • MRUS $61.51
  • KFY $73.13
  • Resistance Level
  • MRUS $64.00
  • KFY $74.41
  • Average True Range (ATR)
  • MRUS 2.32
  • KFY 1.29
  • MACD
  • MRUS 1.02
  • KFY -0.24
  • Stochastic Oscillator
  • MRUS 97.35
  • KFY 49.58

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About KFY Korn Ferry

Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: